ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 735,103 | $8,211 | 3.02% |
BRAIDWELL LP | 1,038,310 | $11,597,923 | 0.37% |
ARMISTICE CAPITAL, LLC | 2,100,000 | $23,457,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 1,875,000 | $20,943,750 | 0.10% |
PDT Partners, LLC | 67,318 | $751,942 | 0.10% |
Virtus ETF Advisers LLC | 12,784 | $142,797 | 0.09% |
Portland Global Advisors LLC | 34,175 | $382 | 0.06% |
XTX Topco Ltd | 27,222 | $304,070 | 0.05% |
Trexquant Investment LP | 132,561 | $1,480,706 | 0.04% |
SHERBROOKE PARK ADVISERS LLC | 10,100 | $112,817 | 0.04% |